By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoCyte Corporation 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


SEARCH JOBS


Industry
Biotechnology






Company News
BioTime (BTX)’s Subsidiary OncoCyte Corporation Announces Completion Of Multi-Site Clinical Study Of Lung Cancer Diagnostic By Collaborators At The Wistar Institute 10/3/2014 7:30:26 AM
BioTime (BTX)'s Subsidiary OncoCyte Corporation's CEO Dr. Joseph Wagner To Present At BTIG’s Inaugural “Emerging Technologies In Healthcare Diagnostics” Symposium 9/19/2014 8:28:40 AM
BioTime (BTX)'s Subsidiary OncoCyte Corporation And Abcodia To Collaborate On Breast Cancer Diagnostic Development 9/15/2014 11:00:54 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Expands Clinical Development Of Bladder Cancer Diagnostic By Initiating A Large Multi-Site Clinical Trial 7/31/2014 10:56:29 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation And Cornell University Enter License Agreement To Accelerate Lung Cancer Diagnostic Product Development 5/27/2014 10:00:32 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Initiates Clinical Development Of Bladder Cancer Diagnostics In The United States And China 1/27/2014 9:32:14 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation and The Wistar Institute to Collaboratively Develop Cancer Diagnostics 10/15/2013 9:53:58 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation Publishes Data on the Gene FSIP1 as a Breast Cancer-Specific Marker 8/5/2013 9:38:14 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM 1/31/2013 10:00:08 AM
BioTime (BTX) and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers 8/16/2012 9:37:37 AM
12
//-->